302 related articles for article (PubMed ID: 17018624)
1. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
[TBL] [Abstract][Full Text] [Related]
2. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model.
Terada N; Shimizu Y; Kamba T; Inoue T; Maeno A; Kobayashi T; Nakamura E; Kamoto T; Kanaji T; Maruyama T; Mikami Y; Toda Y; Matsuoka T; Okuno Y; Tsujimoto G; Narumiya S; Ogawa O
Cancer Res; 2010 Feb; 70(4):1606-15. PubMed ID: 20145136
[TBL] [Abstract][Full Text] [Related]
3. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
[TBL] [Abstract][Full Text] [Related]
4. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
5. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
6. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
7. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis.
Kubo H; Hosono K; Suzuki T; Ogawa Y; Kato H; Kamata H; Ito Y; Amano H; Kato T; Sakagami H; Hayashi I; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Biomed Pharmacother; 2010 Feb; 64(2):101-6. PubMed ID: 20034758
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
Pavco PA; Bouhana KS; Gallegos AM; Agrawal A; Blanchard KS; Grimm SL; Jensen KL; Andrews LE; Wincott FE; Pitot PA; Tressler RJ; Cushman C; Reynolds MA; Parry TJ
Clin Cancer Res; 2000 May; 6(5):2094-103. PubMed ID: 10815937
[TBL] [Abstract][Full Text] [Related]
9. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 stimulates human lung carcinoma cell growth through induction of integrin-linked kinase: the involvement of EP4 and Sp1.
Zheng Y; Ritzenthaler JD; Sun X; Roman J; Han S
Cancer Res; 2009 Feb; 69(3):896-904. PubMed ID: 19176380
[TBL] [Abstract][Full Text] [Related]
11. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh M; Watanabe K; Kitamura T; Shoji Y; Takahashi M; Kawamori T; Tani K; Kobayashi M; Maruyama T; Kobayashi K; Ohuchida S; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
Cancer Res; 2002 Jan; 62(1):28-32. PubMed ID: 11782353
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.
Ma X; Kundu N; Rifat S; Walser T; Fulton AM
Cancer Res; 2006 Mar; 66(6):2923-7. PubMed ID: 16540639
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells.
Takita M; Inada M; Maruyama T; Miyaura C
FEBS Lett; 2007 Feb; 581(3):565-71. PubMed ID: 17254571
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation.
Fushimi K; Nakashima S; You F; Takigawa M; Shimizu K
J Cell Biochem; 2007 Feb; 100(3):783-93. PubMed ID: 17031853
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostanoid EP agonists on mouse intraocular pressure.
Saeki T; Ota T; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
[TBL] [Abstract][Full Text] [Related]
16. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
[TBL] [Abstract][Full Text] [Related]
17. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump.
Lu X; Qin W; Li J; Tan N; Pan D; Zhang H; Xie L; Yao G; Shu H; Yao M; Wan D; Gu J; Yang S
Cancer Res; 2005 Aug; 65(15):6843-9. PubMed ID: 16061667
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.
Galaup A; Cazes A; Le Jan S; Philippe J; Connault E; Le Coz E; Mekid H; Mir LM; Opolon P; Corvol P; Monnot C; Germain S
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18721-6. PubMed ID: 17130448
[TBL] [Abstract][Full Text] [Related]
20. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]